Oppenheimer Initiates Coverage On PolyPid with Outperform Rating, Announces Price Target of $10

Benzinga · 2d ago
Oppenheimer analyst Les Sulewski initiates coverage on PolyPid (NASDAQ:PYPD) with a Outperform rating and announces Price Target of $10.